Updated data request: Ovarian cancer risk factors by histologic subtypes and development of an ovarian cancer risk prediction model in the Ovarian Cancer Cohort Consortium (OC3) |
Nicolas Wentzensen |
DCEG, NCI |
PLCO |
Dec 11, 2018 |
PLCO-429 |
Quantifying risk of prostate cancer in men with inflammatory bowel disease. |
Shilajit Kundu |
Northwestern University Feinberg School of Medicine |
PLCO |
Dec 11, 2018 |
PLCO-428 |
The association of dietary glycemic index and glycemic load on ovarian cancer incidence and survival in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort |
Jennifer Mongiovi |
University at Buffalo |
PLCO |
Dec 11, 2018 |
PLCO-427 |
Clinicopathologic features and machine learning tools to inform clinical outcome in lung cancer |
Arkadiusz Gertych |
Cedars-Sinai Medical Center |
NLST |
Dec 6, 2018 |
NLST-456 |
Benign and malignant pulmonary nodules diagnosis. |
Huang Xiansong |
Department of AI Research, ShenZhen Cyberspace Laboratory |
NLST |
Nov 30, 2018 |
NLST-455 |
Lung nodule characterisation with deep learning |
Julia Schnabel |
Kings College London |
NLST |
Nov 19, 2018 |
NLST-454 |
Lung nodule screening on CT images |
Charubutr Asavaroengchai |
A.I.Brain Co., Ltd |
NLST |
Nov 19, 2018 |
NLST-453 |
Diet, Metabolic Biomarkers and Lung Cancer Risk |
Martin Carl Tammemagi |
Brock University |
PLCO |
Nov 19, 2018 |
PLCO-418 |
Artificial Intelligence -based Computer Aided Early Diagnosis for low dose CT scans |
Jolu Ninan |
Abu Dhabi University |
NLST |
Nov 19, 2018 |
NLST-450 |
Association of obesity with risk of early-onset cancer: based on PLCO dataset |
Gaoxiang Ma |
China Pharmaceutical University |
PLCO |
Nov 19, 2018 |
PLCO-411 |
Establishing Equivalence of Commonly Used Physical Activity Measures Using Testing Equating |
Zezhao Chen |
University of Illinois at Urbana Champaign |
IDATA |
Nov 13, 2018 |
IDATA-28 |
Public Policy Recommendations Towards Colorectal Screenings |
Robert Henderson |
George Mason University |
PLCO |
Nov 13, 2018 |
PLCO-422 |
Estimating heterogeneous treatment effect of lung cancer in PLCO trial |
Yang Zhao |
Nanjing Medical University |
PLCO |
Nov 13, 2018 |
PLCO-424 |
A systematic evaluation of environmental and genetic factors associated with incidence and mortality of prostate, lung, colorectal and ovarian cancer. |
Wendy Lam |
The University of Hong Kong |
PLCO |
Nov 13, 2018 |
PLCO-409 |
Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
PLCO |
Nov 13, 2018 |
PLCO-423 |
Colonoscopy Adenoma Findings in Different Age Are Associated With Diverse Long-term Colorectal Cancer Incidence |
Xuesi Dong |
Nanjing Medical University |
PLCO |
Nov 7, 2018 |
PLCO-420 |
NSAID use and ovarian cancer risk of morbidity and survival |
Jieyu He |
Department of Biostatistics, School of Public Health, Nanjing Medical University |
PLCO |
Nov 7, 2018 |
PLCO-421 |
Association Between Aspirin Use and Risk of Liver Carcinoma: Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and a meta-analysis of 4 cohort studies |
Xuesi Dong |
Nanjing Medical University |
PLCO |
Nov 5, 2018 |
PLCO-419 |
Levels of Trimethylamine Metabolites and Their Associations with Dietary Intakes and Cardiometabolic Biomarkers: the TMAO Pooling Project |
Danxia Yu |
Vanderbilt University Medical Center |
PLCO |
Nov 2, 2018 |
PLCO-414 |
Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Nov 2, 2018 |
PLCO-417 |